| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. (OTCEM:BPTH) through any online brokerage.
There are no as such competitors for BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc..
BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. has a consensus price target of $30.00.
The stock price for BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. (OTCEM: BPTH) is $0.0501 last updated April 23, 2026 at 8:00 AM EDT.
There are no upcoming dividends for BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc..
BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc..
BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
